Brinker Capital Investments’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $223K | Sell |
2,136
-130
| -6% | -$13.6K | ﹤0.01% | 1839 |
|
|
2025
Q1 | $264K | Buy |
+2,266
| New | +$264K | ﹤0.01% | 1683 |
|
|
2024
Q4 | – | Sell |
-2,751
| Closed | -$247K | – | 1826 |
|
|
2024
Q3 | $247K | Sell |
2,751
-53
| -2% | -$4.76K | ﹤0.01% | 1615 |
|
|
2024
Q2 | $226K | Sell |
2,804
-179
| -6% | -$14.4K | ﹤0.01% | 1581 |
|
|
2024
Q1 | $238K | Buy |
2,983
+60
| +2% | +$4.79K | ﹤0.01% | 1550 |
|
|
2023
Q4 | $260K | Sell |
2,923
-440
| -13% | -$39.1K | ﹤0.01% | 1467 |
|
|
2023
Q3 | $235K | Buy |
3,363
+19
| +0.6% | +$1.33K | ﹤0.01% | 1489 |
|
|
2023
Q2 | $240K | Buy |
+3,344
| New | +$240K | ﹤0.01% | 1493 |
|
|
2023
Q1 | – | Sell |
-2,681
| Closed | -$207K | – | 1560 |
|
|
2022
Q4 | $207K | Sell |
2,681
-3,305
| -55% | -$255K | ﹤0.01% | 1284 |
|
|
2022
Q3 | $267K | Buy |
+5,986
| New | +$267K | 0.01% | 1165 |
|
|
2021
Q1 | – | Sell |
-4,507
| Closed | -$367K | – | 1170 |
|
|
2020
Q4 | $367K | Buy |
+4,507
| New | +$367K | 0.01% | 900 |
|